--- title: Here Are the New Drugs and Treatments We Could See in 2024 description: 2024 could bring more effective ways to treat Alzheimer’s, schizophrenia, and hemophilia. canonical: https://time.com/6551640/new-drugs-fda-2024/ author: Alice Park article:opinion: false article:content_tier: free article:published_time: 2024-01-04T19:20:53.000Z article:modified_time: 2026-08-04T07:50:40.252Z article:section: Health og:title: Here Are the New Drugs and Treatments We Could See in 2024 og:description: 2024 could bring more effective ways to treat Alzheimer’s, schizophrenia, and hemophilia. og:url: https://time.com/6551640/new-drugs-fda-2024/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt28489497637ff977/698a438a096a94b0666ae778/GettyImages-1431508910.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 og:image:width: 2176 og:image:height: 1224 og:image:alt: DNA icon in medical pill og:type: article twitter:card: summary_large_image twitter:title: Here Are the New Drugs and Treatments We Could See in 2024 twitter:description: 2024 could bring more effective ways to treat Alzheimer’s, schizophrenia, and hemophilia. twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt28489497637ff977/698a438a096a94b0666ae778/GettyImages-1431508910.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 ---  # Here Are the New Drugs and Treatments We Could See in 2024 > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: September 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=a3bb363f-87a7-4844-969f-f0ed13c2fb28&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Weekdays | | Worth Your Time | A weekly guide to what to watch, read, and more | Weekly | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=a3bb363f-87a7-4844-969f-f0ed13c2fb28&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=a3bb363f-87a7-4844-969f-f0ed13c2fb28&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ### Sources * TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=a3bb363f-87a7-4844-969f-f0ed13c2fb28&cr=time-nl-network-2026q3-v1) ## Video: This Hospital Gives Prescriptions For Healthy Food [Watch (HLS stream): This Hospital Gives Prescriptions For Healthy Food](https://cdn.jwplayer.com/manifests/hzj5uITV.m3u8) (2:37)  _Published 2024-01-04. Boston Medical Center’s Preventive Food Pantry is stocked with vegetables it grows on its roof. The program serves over 7,000 people a month._  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Jan 4, 2024 7:20 PM UTC  3D medicine capsule concept: Close-up on colored edible pill. Genetic molecule symbol in transparent part. Reflection and dropped shadow on white background, clipping path and copy space. Clever Nanotechnology drugs, molecular structure. 3D medicine capsule concept: Close-up on colored edible pill. Genetic molecule symbol in transparent part. Reflection and dropped shadow on white background, clipping path and copy space. Clever Nanotechnology drugs, molecular structure. Getty Images  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Jan 4, 2024 7:20 PM UTC 2023 was a strong year for innovative new drugs, with new medications for [Alzheimer’s disease](https://time.com/6244798/fda-approves-lecanemab-alzheimers-drug/), [weight loss](https://time.com/6333255/fda-approval-zepbound-tirzepatide-mounjaro-weight-loss/), and the [first treatment based on the gene-editing technology CRISPR](https://time.com/6343853/fda-crispr-treatment-sickle-cell/). But 2024 is also shaping up to be a milestone year for some exciting therapies. Here's what to expect. ## Another new Alzheimer's drug Eli Lilly could debut a new [treatment for Alzheimer’s disease](https://time.com/6276651/alzheimers-drug-eli-lilly-donanemab/) that targets amyloid, the protein that builds up in the brains of patients. In [studies](https://time.com/6276651/alzheimers-drug-eli-lilly-donanemab/) that the company has submitted to the U.S. Food and Drug Administration (FDA) for approval, people receiving the drug experienced 35% slower cognitive decline according to cognitive tests than those getting placebo, and 40% less decline in their ability to perform daily activities such as driving or holding conversations. That’s a slightly higher efficacy than the existing medications for the neurodegenerative disease, and experts are hoping that if patients start taking it early enough, they might be able to hold off the worst effects of memory loss and cognitive decline for a few years. The FDA is expected to make a decision about the drug in early 2024. ## Innovative blood-disorder treatments After approving the [first CRISPR treatment,](https://time.com/6343853/fda-crispr-treatment-sickle-cell/) Casgevy, for sickle cell anemia, the FDA is reviewing the same therapy for another genetic blood disorder called beta thalassemia. In both conditions, people have abnormal blood cells that can’t carry enough oxygen, which leads to painful attacks and frequent blood transfusions and hospitalizations. The gene-editing therapy is a one-time treatment that allows people to make more healthy blood cells, which can reduce the number of painful episodes. U.K. health authorities have granted Casgevy conditional marketing authorization, and the FDA is expected to decide in March whether to approve the treatment for beta thalassemia. The agency is also considering other gene-based treatments that don’t use CRISPR but rely on more traditional virus-based methods. One is for hemophilia B. Patients with the condition experience moderate-to-severe bleeding episodes because they lack a coagulation factor that the gene therapy provides. In studies by the manufacturer, Pfizer, the therapy lowered the risk of annual bleeding among a few dozen men who tested it [by 71%](https://www.hematologyadvisor.com/home/topics/bleeding-disorders/hemophilia-fidanacogene-elaparvovec-gene-therapy-promising-treatment/). The FDA is expected to make a decision about the treatment in the second quarter of 2024. ### More From TIME ## A novel schizophrenia drug Later in the year, the FDA will review a [new drug treatment for schizophrenia](https://time.com/6509764/new-drug-compound-schizophrenia/)—the first for the psychiatric condition in decades. Karuna Therapeutics has improved upon existing antipsychotics by targeting a different brain chemical than existing medications, which focus on dopamine. In a study of a couple hundred people with schizophrenia, the drug, which works on the muscarinic receptors in the brain involved in regulating positive and negative thoughts, helped to reduce the extremes of symptoms that are typical of the condition. If approved, the drug could help more people with schizophrenia relieve their worst symptoms, since many people stop taking the existing medications because of their side effects. ## New year, same old questions of access As exciting as the possible new medications are, they also raise [questions about affordability and accessibility](https://time.com/6292501/fda-approval-alzheimers-drug-leqembi-lecanemab/). Innovative drug treatments involving gene therapy and CRISPR, for example, are designed to be one-time treatments that can mitigate the need for repeated and often lifelong medical care. But that means higher upfront costs, and it’s not clear whether insurers will cover such hefty price tags. As more therapies reach the market, however, they could change the reimbursement structure as insurers will likely feel increasing pressure to cover treatments that could be not just life-changing but also potentially curative—and save millions in long-term health care costs. ## Transcript It started as simple as when it be great if we can grow food for a patient. So my way to level in spinach that's on the menu. We say we grow right outside your patient window. So it's a pretty cool thing. We're actually a very sustainably minded organization would have been a lot of work around energy. So having a green roof and we knew there was a greater benefit to the community we serve in probably mentally. You get prescribed that first time you can come to the PNP as long as you want. So like you don't have to keep getting a new prescription like we do from a regular medicines. You can come today. And then for the next five years if you feel that your family needs it because your food in Sakura. We're going to provide food for your family. And if you want a diabetic diet will feed you Foods based on a diabetic diet. So it's not sugary taste is healthy based. Based on our programming in our patients how diverse they have in the pantry. We are even growing a lot of crops that are not a native to the US native to Africa and make her another countries. We called culturally important crops we just got to do in that two seasons ago has been very popular like peppers from Puerto Rico and some other batch with some other leafy greens are really inspiration was to address of food in Sakura patients, but a greater goal was to create a food resilient infrastructure in the community. We serve we want to make Boston the healthiest Urban population in the world looks like his not having a pantry like not needing a pantry but patients or patients of food resilient. Really what we tried to do is we're trying to teach classes up there. We were Show people how to grow do I need to learn how to cook with these different vegetables for always trying to think I've sprained, you know, how we can curb the need for a food pantry other need some some of these out of The Little Clinic some things that were providing. ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6551640/new-drugs-fda-2024/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6551640/new-drugs-fda-2024/"},"headline":"Here Are the New Drugs and Treatments We Could See in 2024","datePublished":"2024-01-04T19:20:53.000Z","dateModified":"2026-08-04T07:50:40.252Z","description":"2024 could bring more effective ways to treat Alzheimer’s, schizophrenia, and hemophilia.","url":"https://time.com/6551640/new-drugs-fda-2024/","keywords":["Drugs","healthscienceclimate"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt28489497637ff977/698a438a096a94b0666ae778/GettyImages-1431508910.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt28489497637ff977/698a438a096a94b0666ae778/GettyImages-1431508910.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"DNA icon in medical pill","caption":"DNA icon in medical pill","creditText":"Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/drugs/","name":"Drugs"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/6551640/new-drugs-fda-2024/","name":"Here Are the New Drugs and Treatments We Could See in 2024"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"This Hospital Gives Prescriptions For Healthy Food","description":"Boston Medical Center’s Preventive Food Pantry is stocked with vegetables it grows on its roof. The program serves over 7,000 people a month.","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/hzj5uITV/poster.jpg?width=720","uploadDate":"2024-01-04T18:02:01.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/hzj5uITV.m3u8","embedUrl":"https://time.com/6551640/new-drugs-fda-2024/","duration":"PT2M37S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/6551640/new-drugs-fda-2024/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```